JCarlCraftMD

PubMed

• 5 citations
  Phase 3 trial of treating gonorrhoea with solithromycin.
  Prabhavathi Fernandes, J. Carl Craft> ;The Lancet. Infectious Diseases. 2019 Sep 1
• 34 citations
  Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis.
  R. Lu, Christopher Hollingsworth, Jin Qiu, Amy Wang, E. Hughes, X. Xin, K. M. Konrath, Waleed Elsegeiny, Yoon-Dong Park, L. Atakulu, J. C. Craft, Edmund C. Tramont, R....> ;Mbio. 2019 May 28
• 14 citations
  Trajectory assessment is useful when day-to-day esophageal acid exposure varies in prolonged wireless pH monitoring
  Rena Yadlapati, Jody D. Ciolino, J. Craft, Sabine Roman, John E. Pandolfino> ;Diseases of the Esophagus. 2019 Mar 1
• 55 citations
  Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of...
  David Oldach, Kay Clark, Jennifer Schranz, Anita Das, J. Carl Craft, Drusilla Scott, Brian D. Jamieson, Prabhavathi Fernandes> ;Antimicrobial Agents and Chemotherapy. 2013 Jun 1
• 93 citations
  Review of pyronaridine anti-malarial properties and product characteristics.
  Simon L. Croft, Stephan Duparc, Sarah Arbe-Barnes, J. Carl Craft, Chang Sik Shin, Lawrence Fleckenstein, Isabelle Borghini-Fuhrer, Han Jong Rim> ;Malaria Journal. 2012 Aug 9
• 78 citations
  First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials
  Joerg J. Moehrle, Stephan Duparc, Christoph Siethoff, Paul L. M. van Giersbergen, J. Carl Craft, Sarah Arbe-Barnes, Susan A. Charman, Maria Gutierrez, Sergio Wittlin, ...> ;British Journal of Clinical Pharmacology. 2013 Feb 1
• 11 citations
  In Vitro and In Vivo Activity of Solithromycin (CEM-101) Against Plasmodium Species
  Sergio Wittlin, Eric H. Ekland, J. Carl Craft, Julie Lotharius, Ian Bathurst, David A. Fidock, Prabhavathi Fernandes> ;Antimicrobial Agents and Chemotherapy. 2012 Feb 1
• 36 citations
  A Randomized, Double-Blind Phase 2 Study Comparing the Efficacy and Safety of an Oral Fusidic Acid Loading-Dose Regimen to Oral Linezolid for the Treatment of Acute Ba...
  J. Carl Craft, Susan R. Moriarty, Kay Clark, Drusilla Scott, Thorsten P. Degenhardt, J. Gordon Still, G. Ralph Corey, Anita Das, Prabhavathi Fernandes> ;Clinical Infectious Diseases. 2011 Jun 1
• 270 citations
  Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
  Susan A. Charman, Sarah Arbe-Barnes, Ian Bathurst, Reto Brun, Michael Campbell, William N. Charman, Francis C. K. Chiu, Jacques Chollet, J. Carl Craft, Darren J. Creek...> ;Proceedings of the National Academy of Sciences of the United States of America. 2011 Mar 15
• 11 citations
  Comparative embryotoxicity of different antimalarial peroxides: in vitro study using the rat whole embryo culture model (WEC).
  Monica Longo, Sara Zanoncelli, Marco Brughera, Paolo Colombo, Sergio Wittlin, Jonathan L. Vennerstrom, Joerg J. Moehrle, J. Carl Craft> ;Reproductive Toxicology. 2010 Dec 1
• 15 citations
  Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects
  Beesan Tan, Himanshu Naik, In-Jin Jang, Kyung Sang Yu, Lee E. Kirsch, Chang-Sik Shin, J. Carl Craft, Lawrence Fleckenstein> ;Malaria Journal. 2009 Dec 18
• 22 citations
  Challenges facing drug development for malaria.
  J Carl Craft> ;Current Opinion in Microbiology. 2008 Oct 1
• Role for macrophage migration inhibitory factor in asthma.
  Mizue Y, Ghani S, Leng L, McDonald C, Kong P, Baugh J, Lane SJ, Craft J, Nishihira J, Donnelly SC, Zhu Z, Bucala R> ;Proc. Natl. Acad. Sci. U.S.A.. 2005-10-04
• 11 citations
  Medicines for Malaria Venture new developments in antimalarials.
  Solomon Nwaka, Lise Riopel, David Ubben, J. Carl Craft> ;Travel Medicine and Infectious Disease. 2004 Aug 1
• 18 citations
  Macrolide Therapy of Group A Streptococcal Pharyngitis: 10 Days of Macrolide Therapy (Clarithromycin) Is More Effective in Streptococcal Eradication than 5 Days (Azith...
  Edward L. Kaplan, W. Manfred Gooch, Gerard F. Notario, J. Carl Craft> ;Clinical Infectious Diseases. 2001 Jun 15
• 7 citations
  Ketolide ABT-773 is active against Toxoplasma gondii
  Anis A. Khan, Fausto G. Araujo, J. Carl Craft, Jack S. Remington> ;The Journal of Antimicrobial Chemotherapy. 2000 Sep 1
• Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies.
  Nagaraju K, Raben N, Loeffler L, Parker T, Rochon PJ, Lee E, Danning C, Wada R, Thompson C, Bahtiyar G, Craft J, Hooft Van Huijsduijnen R, Plotz P> ;Proc. Natl. Acad. Sci. U.S.A.. 2000-08-01
• 391 citations
  Dialectical Behavior Therapy for Patients with Borderline Personality Disorder and Drug-Dependence
  Marsha M. Linehan, Henry Schmidt Iii, Linda A. Dimeff, J. Christopher Craft, Jonathan W. Kanter, Katherine Anne Comtois> ;The American Journal on Addictions. 1999 Oct 1
• 8 citations
  Clarithromycin Resistance and Susceptibility Patterns of Mycobacterium avium Strains Isolated During Prophylaxis for Disseminated Infection in Patients with AIDS
  J. Carl Craft, Gerard F. Notario, Jacques H. Grosset, Leonid B. Heifets> ;Clinical Infectious Diseases. 1998 Oct 1
• 27 citations
  Steady-State Pharmacokinetics and Electrocardiographic Pharmacodynamics of Clarithromycin and Loratadine after Individual or Concomitant Administration
  Robert A. Carr, Anthony Edmonds, Harry Shi, Charles Locke, Gustavson Linda E, J. Carl Craft, Stuart I. Harris, Palmer Robert N> ;Antimicrobial Agents and Chemotherapy. 1998 May 1
• 97 citations
  Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
  Richard E. Chaisson, Philip Keiser, Mark A. Pierce, W. Jeffrey Fessel, Joel Ruskin, Christopher Lahart, Constance A. Benson, Kysa Meek, Nancy Siepman, J. Carl Craft> ;AIDS. 1997 Mar 1
• 6 citations
  Ancillary benefits of Mycobacterium avium-intracellulare complex prophylaxis with clarithromycin in HIV-infected patients.
  H. Jablonowski, G. Fätkenheuer, M. Youle, T. Newell, S. Lines, J. C. Craft> ;Drugs. 1997 Jan 1
• Association of RNase mitochondrial RNA processing enzyme with ribonuclease P in higher ordered structures in the nucleolus: a possible coordinate role in ribosome biog...
  Lee B, Matera AG, Ward DC, Craft J> ;Proc. Natl. Acad. Sci. U.S.A.. 1996-10-15
• 232 citations
  Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsucci...
  Stan L. Block, James Hedrick, Margaret R. Hammerschlag, Gail H. Cassell, J. Craft> ;The Pediatric Infectious Disease Journal. 1995 Jun 1
• 197 citations
  Clarithromycin Therapy for Bacteremic Mycobacterium avium Complex Disease: A Randomized, Double-Blind, Dose-Ranging Study in Patients with AIDS
  Richard E. Chaisson, Constance A. Benson, Michael P. Dubé, Leonid B. Heifets, Joyce A. Korvick, Saralyn Elkin, Ted Smith, J. Carl Craft, Fred R. Sattler> ;Annals of Internal Medicine. 1994 Dec 15
• Join now to see all